Bu Fanqiang, Liu Mengnan, Xie Zixu, Chen Xinyu, Li Guofeng, Wang Xing
State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
Pharmaceuticals (Basel). 2022 Oct 12;15(10):1253. doi: 10.3390/ph15101253.
Biofilm is a crucial virulence factor for microorganisms that causes chronic infection. After biofilm formation, the bacteria present improve drug tolerance and multifactorial defense mechanisms, which impose significant challenges for the use of antimicrobials. This indicates the urgent need for new targeted technologies and emerging therapeutic strategies. In this review, we focus on the current biofilm-targeting strategies and those under development, including targeting persistent cells, quorum quenching, and phage therapy. We emphasize biofilm-targeting technologies that are supported by blocking the biofilm life cycle, providing a theoretical basis for design of targeting technology that disrupts the biofilm and promotes practical application of antibacterial materials.
生物膜是导致慢性感染的微生物的关键毒力因子。生物膜形成后,其中存在的细菌会提高耐药性和多因素防御机制,这给抗菌药物的使用带来了重大挑战。这表明迫切需要新的靶向技术和新兴治疗策略。在本综述中,我们重点关注当前的生物膜靶向策略以及正在开发的策略,包括靶向持久性细胞、群体感应淬灭和噬菌体疗法。我们强调通过阻断生物膜生命周期来支持的生物膜靶向技术,为破坏生物膜的靶向技术设计提供理论基础,并促进抗菌材料的实际应用。